Voloridge Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-97,175
| Closed | -$14.7M | – | 1709 |
|
|
2022
Q3 | $14.7M | Sell |
97,175
-32,744
| -25% | -$4.95M | 0.08% | 337 |
|
|
2022
Q2 | $18.9M | Buy |
129,919
+49,367
| +61% | +$7.19M | 0.1% | 280 |
|
|
2022
Q1 | $9.55M | Sell |
80,552
-41,394
| -34% | -$4.91M | 0.05% | 420 |
|
|
2021
Q4 | $16.8M | Sell |
121,946
-59,958
| -33% | -$8.26M | 0.09% | 307 |
|
|
2021
Q3 | $25.3M | Buy |
181,904
+170,177
| +1,451% | +$23.6M | 0.16% | 145 |
|
|
2021
Q2 | $1.14M | Sell |
11,727
-13,203
| -53% | -$1.28M | 0.01% | 1206 |
|
|
2021
Q1 | $1.7M | Sell |
24,930
-805
| -3% | -$55K | 0.01% | 868 |
|
|
2020
Q4 | $2.21M | Sell |
25,735
-41,261
| -62% | -$3.54M | 0.02% | 701 |
|
|
2020
Q3 | $4.36M | Sell |
66,996
-20,457
| -23% | -$1.33M | 0.04% | 482 |
|
|
2020
Q2 | $6.39M | Buy |
87,453
+79,053
| +941% | +$5.78M | 0.07% | 297 |
|
|
2020
Q1 | $286K | Buy |
+8,400
| New | +$286K | 0.01% | 887 |
|
|
2019
Q2 | – | Sell |
-12,964
| Closed | -$667K | – | 1257 |
|
|
2019
Q1 | $667K | Buy |
+12,964
| New | +$667K | 0.02% | 594 |
|